CALABRO', Maria
 Distribuzione geografica
Continente #
EU - Europa 7.259
NA - Nord America 7.060
AS - Asia 3.811
SA - Sud America 1.101
Continente sconosciuto - Info sul continente non disponibili 114
AF - Africa 98
OC - Oceania 5
Totale 19.448
Nazione #
US - Stati Uniti d'America 6.955
RU - Federazione Russa 3.502
SG - Singapore 1.594
CN - Cina 1.141
BR - Brasile 976
IE - Irlanda 930
SE - Svezia 804
UA - Ucraina 504
DE - Germania 419
HK - Hong Kong 401
VN - Vietnam 262
IT - Italia 251
GB - Regno Unito 230
FR - Francia 212
FI - Finlandia 209
IN - India 114
CA - Canada 54
TR - Turchia 48
AR - Argentina 40
BD - Bangladesh 40
PL - Polonia 37
IQ - Iraq 33
MX - Messico 32
BE - Belgio 31
ZA - Sudafrica 29
ES - Italia 24
EC - Ecuador 23
IR - Iran 23
NL - Olanda 22
JP - Giappone 21
AT - Austria 20
MA - Marocco 19
PK - Pakistan 18
ID - Indonesia 17
UZ - Uzbekistan 17
CO - Colombia 16
CI - Costa d'Avorio 14
VE - Venezuela 13
TN - Tunisia 12
CZ - Repubblica Ceca 11
AZ - Azerbaigian 9
CL - Cile 8
MY - Malesia 8
PE - Perù 8
PY - Paraguay 8
SA - Arabia Saudita 8
CR - Costa Rica 7
DZ - Algeria 7
IL - Israele 7
KE - Kenya 7
LV - Lettonia 7
NP - Nepal 7
RS - Serbia 6
AE - Emirati Arabi Uniti 5
EE - Estonia 5
EU - Europa 5
KZ - Kazakistan 5
OM - Oman 5
PH - Filippine 5
AL - Albania 4
CH - Svizzera 4
ET - Etiopia 4
SN - Senegal 4
UY - Uruguay 4
BN - Brunei Darussalam 3
DK - Danimarca 3
GR - Grecia 3
KR - Corea 3
MD - Moldavia 3
SK - Slovacchia (Repubblica Slovacca) 3
SR - Suriname 3
AM - Armenia 2
AU - Australia 2
GE - Georgia 2
HR - Croazia 2
JM - Giamaica 2
JO - Giordania 2
KG - Kirghizistan 2
LT - Lituania 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
QA - Qatar 2
RO - Romania 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
EG - Egitto 1
GT - Guatemala 1
GY - Guiana 1
LB - Libano 1
LU - Lussemburgo 1
MK - Macedonia 1
ML - Mali 1
Totale 19.331
Città #
Moscow 1.064
Jacksonville 950
Dublin 930
Singapore 819
Ashburn 777
Chandler 601
Nyköping 482
Dallas 414
San Jose 413
Hong Kong 400
Beijing 361
Council Bluffs 260
Dearborn 167
The Dalles 165
Princeton 154
Cambridge 152
Medford 152
Dong Ket 140
Lauterbourg 139
Los Angeles 134
Des Moines 127
Ann Arbor 118
Boardman 106
Tianjin 74
Buffalo 69
Guangzhou 64
São Paulo 64
New York 62
Munich 58
Woodbridge 57
Jinan 55
Lancaster 55
Ho Chi Minh City 51
Columbus 50
Messina 49
Wilmington 44
San Mateo 41
Redondo Beach 39
Shenyang 39
Rio de Janeiro 36
Turku 33
Houston 32
Bremen 31
Brussels 31
Warsaw 31
Pune 29
Atlanta 28
Augusta 27
Nanjing 26
Santa Clara 25
Brasília 23
Frankfurt am Main 23
Montreal 23
Chennai 22
Orem 22
Shanghai 22
Belo Horizonte 21
Leawood 21
Brooklyn 20
Campinas 20
Chicago 20
Helsinki 20
Phoenix 20
Tokyo 20
Hangzhou 19
Hanoi 19
Nanchang 19
Shenzhen 19
Milan 18
Seattle 18
Ardabil 17
Haikou 17
Rome 17
Vienna 17
Hebei 16
Ningbo 16
Tashkent 16
Abidjan 14
Amsterdam 14
Mexico City 14
Porto Alegre 14
Taizhou 14
Johannesburg 13
London 13
Manchester 13
Mumbai 13
Washington 13
Curitiba 12
San Francisco 12
Auburn Hills 11
Boston 11
Francofonte 11
Guayaquil 11
Hyderabad 11
Manaus 11
Poplar 11
Taiyuan 11
Baghdad 10
Fortaleza 10
Goiânia 10
Totale 11.027
Nome #
{ [1.1.1.] CRYPTAND/THYMOL BLUE } : A PROTOTYPE OF MOLECULAR APPARATUS FOR SPECTROPHOTOMETRIC AUTOMATIC STUDIES 271
A CHEMOMETRIC APPROACH FOR THE SEPARATION OF SOME PSYCHOTROPIC DRUGS AND THEIR METABOLITES BY LIQUID CHROMATOGRAPHY 256
{[1.1.1.]CRYPTAND/THYMOL BLUE}: A PROTOTYPE OF MOLECULAR APPARATUS FOR SPECTROPHOTOMETRIC AUTOMATIC STUDIES ON PH-RATE PROFILE OF DRUGS 230
Bergamot (Citrus bergamia Risso) as a source of nutraceuticals: Limonoids and flavonoids 225
Cap. 21 - Antitrombotici 203
Isoflavone Aglycons-Sulfobutil Ether-beta-Cyclodextrin Inclusion Complexes: in Solution and Solid State Studies 201
An experimental design methodology applied to the enantioseparation of a non-steroidal anti-inflammatory drug candidate 197
ANALYSES AND DETERMINATION OF LONIDAMINE RELEASE FROM PHARMACEUTICAL FORMULATION. 189
Combined effect of pH and polysorbates with cyclodextrins on solubilization of naringenin 188
ANALYSES AND DETERMINATION OF LONIDAMINE RELEASE FROM PHARMACEUTICAL FORMULATION. 183
Rapid isolation, reliable characterization, and water solubility improvement of polymethoxyflavones from cold-pressed mandarin essential oil 183
Comparative photodegradation studies on 3-hydroxyflavone: influence of different media, pH and light sources 181
Study of beta-blockers/beta-cyclodextrins inclusion complex by NMR, DSC, X-ray and SEM investigation 178
BETA-BLOCKERS CHARACTERIZATION BY UV-VIS ABSORPTION AND REFLECTIVITY IN DIFFERENT CHEMICAL ENVIRONMENTS 178
A novel HPLC method for the determination of mitoxantrone in pharmaceutical formulations. 177
ANALYSIS OF PYRROLIDONIC COMPOUNDS AS POTENTIAL ANTIOXIDANT. 177
CARATTERIZZAZIONE DI COMPLESSI D'INCLUSIONE FLAVONOIDI/CICLODESTRINE MEDIANTE:DSC,RAGGI X,DRIFT,UV-VIS 176
A STUDY OF THE INCLUSION COMPLEX OF ATENOLOL WITH BETA-CYCLODEXTRIN 175
The rutin/beta-cyclodextrin interactions in fully aqueous solution: spectroscopic studies and biological assays 173
Characterization of limonoids in citrus essential oils by means of supercritical fluid chromatography tandem mass spectrometry (SFC-QqQ MS) 173
COMBINED EFFECT OF pH AND CYCLODEXTRINS ON SOLUBILIZATION OF NARINGENIN 172
Analytical profile and release of lonidamine from pharmaceutical formulation 172
CORDIA FRANCISCI, C, MARTINICENSIS, C. MYXA, C. SERRATIFOLIA AND C. ULMIFOLIA LEAVES AS NEW SOURCES OF RUTIN: ANALGESIC AND ANTI-INFLAMMATORY ACTIVITY. 171
Characterization and isolation of limonoids in by-products of Citrus essential oils industry by means of liquid chromatography 170
Cold-pressed lemon essential oil by-products: enhancement through bioactive molecules isolation 169
AN EXPERIMENTAL DESIGN METHODOLOGY APPLIED TO THE CHIRAL SEPARATION OF A NON-STEROIDAL ANTI-INFLAMMATORY DRUG CANDIDATE 167
COMPARATIVE PHOTODEGRADATION STUDIES: INFLUENCE OF DIFFERENT MEDIA AND LIGHT SOURCES 164
ANALISI DI FLUNARIZINA BICLORIDRATO IN FORME FARMACEUTICHE MEDIANTE CROMATOGRAFIA LIQUIDA AD ALTA PRESSIONE 160
ANALYSIS OF PYRROLIDONIC COMPOUNDS AS POTENTIAL ANTIOXIDANT. 160
CHROMATOGRAPHIC INVESTIGATIONS ON BROTIZOLAM 159
CONFORMATIONAL SEARCH OF PHENYL SUBSTITUTED GAMMA-LACTAMIC DERIVATIVES. 159
Cromatografia liquida ad alta efficienza nell'analisi farmaceutica: separazione e determinazione di una miscela diuretica-antipertensiva 158
Direct separation of the enantiomers of reboxetine by liquid chromatography on different cellulose- and amylose-based chiral stationary phases 158
Drug combination studies of isoquinolinone AM12 with curcumin or quercetin: a new combination strategy to synergistically inhibit 20S proteasome 157
ENANTIOSEPARATION AND COMPLEXATION STUDIES ON 2,3-BENZODIAZEPINES 157
BROTIZOLAM: ANALISI E DETERMINAZIONE MEDIANTE TECNICHE CROMATOGRAFICHE. 156
Optimization of a LC method for the enantio separation of a non-competitive glutamate receptor antagonist, by experimental design methodology 155
SEPARAZIONE E DETERMINAZIONE MEDIANTE HPLC IN FASE INVERSA DI DERIVATI DEL 2-FENILCROMONE E DELL'ACIDO CLOROGENICO DA ESTRATTI DI CRATAEGUS OXYACANTHA L. 151
REAZIONI UV-INDOTTE:FOTOCHIMICA DI COMPLESSI D'INCLUSIONE FLAVONOIDI/CICLODESTRINE. Nota II 149
UV-vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-beta-cyclodextrin inclusion complex 149
Synthesis, Chiral Resolution and Pharmacological Evaluation of a 2,3-Benzodiazepine-Derived Noncompetitive AMPA Receptor Antagonist 148
RUTIN INCLUSION SYSTEMS WITH ALFA AND BETA-CYCLODEXTRINS: CIRCULAR DICHROISM, UV ABSORPTION SPECTROSCOPY AND ANTIOXIDANT ACTIVITY STUDIES 147
Development of Novel Peptidomimetics Containing a VinylSulfone Moiety as Proteasome Inhibitors 147
OPTIMIZED ENANTIOSELECTIVE HPLC METHOD FOR THE ANALYSIS OF TETRAHYDROISOQUINOLINES 144
Study of the extraction procedure by experimental design and validation of a LC method for determination of flavonoids in Citrus bergamia juice 143
INCLUSION COMPLEXES OF SOME FLAVANONES AND THEIR GLYCOSIDES WITH MODIFIED BETA-CYLODEXTRINS 143
Determination of fludarabine in a pharmaceutical formulation by LC 142
SPECTROSCOPIC INVESTIGATION OF INCLUSION COMPLEX OF 9-FLUORENONIC DERIVATIVE WITH (2-HYDROXYPROPYL)-BETA-CYD 142
HPLC/PDA/MS and preparative HPLC-HPLC/PDA/MS for the characterization and isolation of limonoids in bergamot (Citrus bergamia Risso) 139
Cap.21. Antitrombotici 139
Valorizzazione degli scarti dell'industria agroalimentare mediante l'isolamento di molecole bioattive. 138
HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY. SEPARATION AND IDENTIFICATION OF FLAVONOIDS IN CRATAEGUS OXYACANTHA L. Note IV. Apigenin, Apigenin-7-glucoside, Luteolin, Luteolin-3',7-diglucoside 136
Screening and Isolation of Citrus Bioactives by Preparative Liquid Chromatography Coupled to Photo-diode array and Mass Spectrometry Detection 136
Structural and spectroscopic features of lutein/butanoyl-beta-cyclodextrin nanoassemblies 133
Effects of alpha and beta-cyclodextrin complexation on the physico-chemical properties and antioxidant activity of some 3-hydroxyflavones 132
Development of extraction method for characterization of free and bonded polyphenols in barley (Hordeum vulgare L.) grown in Czech Republic using liquid chromatography-tande, mass spectrometry 132
Improvement in solubility and dissolution rate of flavonoids by complexation with beta-cyclodextrin 131
Selective reversed-phase liquid chromatography method for the kinetic investigation of 3-hydroxyflavone photostability 131
BROTIZOLAM: ANALISI E DETERMINAZIONE MEDIANTE TECNICHE CROMATOGRAFICHE. 131
MISURE DI LIPOFILICITA' DI FLAVONI MEDIANTE CROMATOGRAFIA LIQUIDA IN FASE INVERSA 129
Validation of a LC method for the analysis of oxaliplatin in a pharmaceutical formulation using an experimental design 128
Study of the inclusion complex of atenolol with beta- cyclodextrins 128
Cromatografia liquida nell'analisi farmaceutica: determinazione nelle compresse della famotidina, nuovo H2-antagonista 126
Determinazione del trans-1-bis(4-fluorofenil)metil-4-(3-fenil-2-propenil)piperazina dicloridrato mediante HPLC 126
The inclusion complexes of hesperetin and its 7-rhamnoglucoside with (2-hydroxypropyl)-beta-cyclodextrin 124
ISOFLAVONES AND CYCLODEXTRINS: EVIDENCES OF COMPLEXATION BY COMPLEMENTARY SPECTROSCOPIC TECHNIQUES 124
MOLECULAR MODELING OF ENANTIOSELECTIVE RECOGNITION BETWEEN GAMMA-LACTAMIC DERIVATIVES AND CHIRALCEL OD CHIRAL STATIONARY PHASE. 123
UV-INDUCED REACTIONS:EFFECTS OF MICROENVIROMENT ON FLAVONOIDS PHOTOCHEMISTRY 122
HPLC DIASTEREO ED ENANTIOSELETTIVA DI 2-ARIL-4-TIAZOLIDINONI SOSTITUITI. 122
TECNICHE CHEMOMETRICHE PER L'OTTIMIZZAZIONE DI METODOLOGIE STRUMENTALI IN ANALISI FARMACEUTICA 121
Dosaggio mediante HPLC di atenololo e clortalidone associati in forme farmaceutiche 117
STUDI COMPUTAZIONALI NELLA RICOGNIZIONE CHIRALE DI DERIVATI GAMMA-LATTAMICI AD AZIONE ANTIOSSIDANTE 116
Study of flavonoids/beta-cyclodextrins inclusion complexes by NMR, FT-IR, DSC, X-ray investigation 116
CROMATOGRAFIA LIQUIDA NELL'ANALISI FARMACEUTICA: SEPARAZIONE E DETERMINAZIONE DI FAMOTIDINA, NUOVO H2-ANTAGONISTA 115
FORCE FIELD COMPARISONS AND CONFORMATIONAL ANALYSIS OF STRUCTURES INTERESTING IN PHARMACEUTICAL RESEARCH. 115
HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND DIFFUSE REFLECTANCE SPECTROSCOPY OF FLAVONOIDS IN CRATEGUS-OXYACANTHA L .3. ANALYSIS OF 2-PHENYL-CHROMAN DERIVATIVES AND CAFFEIC ACID 115
CORDIA FRANCISCI, C. MARTINICENSIS, C. MYXA, C. SERRATIFOLIA AND C. ULMIFOLIA LEAVES: A NEW SOURCES OF RUTIN. ANALGESIC AND ANTIINFLAMMATORY ACTIVITY 114
Synthesis and biological evaluation of new 2-amino-6-(trifluoromethoxy)benzoxazole derivatives, analogues of riluzole. 114
Diastereo-enantioseparation of N-Acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives on cellulose chiral stationary phases 113
DIRECT ENANTIOMERIC SEPARATION OF REBOXETINE BY LIQUID CHROMATOGRAPHY USING DIFFERENT CELLULOSE AND AMYLOSE BASED CHIRAL STATIONARY PHASES 113
RISOLUZIONE ENANTIOMERICA DI GAMMA-LATTAMI MEDIANTE HPLC. 112
CROMATOGRAFIA LIQUIDA AD ALTA RISOLUZIONE NELL'ANALISI DI PREPARAZIONI ESTRATTIVE DI FOGLIE E GERMOGLI DI OLEA EUROPAEA L. 110
Synthesis of benzothiazole derivatives and their biological evaluation as anticancer agents 110
STRUCTURAL AND CONFORMATIONAL STUDY OF BETA-BLOCKERS/BETA-CYCLODEXTRIN COMPLEXES 109
Sensitive and specific determination of epirubicin and epirubicinol by HPLC. 108
PHOTODEGRADATION STUDY ON 3-HYDROXYFLAVONE BY HPLC. 107
HPLC-DAD AND TLC OF FLAVONOIDS FROM LEAF EXTRACTIVES OF GENUS CORDIA. 107
Diastereo-enantioseparation of novel gamma-lactamic derivatives on cellulose chiral stationary phases 106
PHARMACEUTICAL APPLICATION OF BETA-CYCLODEXTRIN: INCLUSION COMPLEXES WITH BETA-BLOCKERS 105
HYDRATATION EFFECT ON THE MICELLAR STRUCTURE OF TRI-BLOCK COPOLYMER IN WATER (VISCOELASTIC RESULTS). 105
STRUCTURAL AND THERMODYNAMIC STUDY OF BETA-BLOCKERS/BETA-CYCLODEXTRIN INCLUSION COMPLEXES 104
Dosaggio HPLC della roxatidina, prove di stabilità e rilascio da formulazioni farmaceutiche. 104
ENANTIOMERIC SEPARATION BY HPLC OF FLAVANONES AND FLAVANS WITH ANTIOXYDANT ACTIVITY. 103
FORCE FIELD COMPARISONS AND CONFORMATIONAL ANALYSIS OF STRUCTURES INTERESTING IN PHARMACEUTICAL RESEARCH. 103
VALIDATION OF A LIQUID CROMATOGRAPHIC METHOD FOR THE ANALYSIS OF ZAFIRLUKAST IN A PHARMACEUTICAL FORMULATION 102
IMPROVEMENT OF FLAVONOIDS DISSOLUTION PROPERTIES BY COMPLEXATION WITH BETA-CYCLODEXTRIN 102
VALIDATION OF A LC METHOD FOR THE ANALYSIS OF OXALIPLATIN IN A PHARMACEUTICAL FORMULATION USING EXPERIMENTAL DESIGN 101
MODIFIED CYCLODEXTRINS IN THE SOLUBILIZATION OF SOME PHYTOESTROGENS 101
ENANTIOMERIC SEPARATION BY HPLC OF FLAVANONES AND FLAVANS WITH ANTIOXYDANT ACTIVITY. 101
HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY OF FLAVONOIDS IN CRATAEGUS-OXYACANTHA L .4. REVERSED-PHASE HIGH-PRESSURE LIQUID- CHROMATOGRAPHY IN FLOWER, LEAF AND BUD EXTRACTIVES OF CRATAEGUS-OXYACANTHA L 101
Totale 14.383
Categoria #
all - tutte 64.580
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.580


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022842 0 0 0 28 20 2 80 44 6 126 202 334
2022/20232.743 198 197 137 191 259 263 52 170 1.128 12 110 26
2023/2024488 62 93 39 59 54 103 7 18 0 22 2 29
2024/20252.707 35 32 54 180 122 30 48 611 704 159 237 495
2025/20267.826 374 445 515 522 643 1.865 1.109 915 924 293 100 121
2026/20271.095 118 433 429 115 0 0 0 0 0 0 0 0
Totale 19.448